U.S. markets open in 1 hour 43 minutes

  • S&P Futures

    4,483.25
    +7.75 (+0.17%)
     

  • Dow Futures

    35,341.00
    +60.00 (+0.17%)
     

  • Nasdaq Futures

    15,342.00
    +37.50 (+0.25%)
     

  • Russell 2000 Futures

    2,217.20
    +10.60 (+0.48%)
     

  • Crude Oil

    66.73
    +1.09 (+1.66%)
     

  • Gold

    1,807.60
    +1.30 (+0.07%)
     

  • Silver

    23.75
    +0.09 (+0.40%)
     

  • EUR/USD

    1.1744
    -0.0006 (-0.05%)
     

  • 10-Yr Bond

    1.2550
    0.0000 (0.00%)
     

  • Vix

    17.18
    -1.38 (-7.44%)
     

  • GBP/USD

    1.3724
    +0.0000 (+0.00%)
     

  • USD/JPY

    109.6500
    -0.0300 (-0.03%)
     

  • BTC-USD

    49,371.39
    -965.96 (-1.92%)
     

  • CMC Crypto 200

    1,250.15
    -13.29 (-1.05%)
     

  • FTSE 100

    7,092.07
    -16.95 (-0.24%)
     

  • Nikkei 225

    27,732.10
    +237.86 (+0.87%)
     

Innovative Embolic Device for Treating Tumors Highlighted in "BEST of GEST" Session at the Global Embolization Oncology Symposium Technologies ("GEST") Conference

·2 min read

Fluidx Medical's GPX™ Embolic Device Use for Tumor Treatments Chosen for "BEST of GEST" Embolization Program at the Annual GEST Meeting

SALT LAKE CITY, Aug. 24, 2021 /PRNewswire/ -- Fluidx Medical Technology's GPX Embolic Device was selected for a Global Embolization Oncology Symposium Technologies ("GEST") "BEST of GEST" session highlighting the technology's ability to devascularize tumors during minimally-invasive transcatheter embolization procedures (https://gest2021.gestweb.org/program/program/107/oral-abstracts-renal).

Renal Tumor Embolization Using GPX Embolic Device - Christchurch Hospital, Christchurch, New Zealand
Renal Tumor Embolization Using GPX Embolic Device - Christchurch Hospital, Christchurch, New Zealand

"The versatility of the GPX product has been demonstrated in a variety of interventional oncology uses," said Andrew Holden, M.D., MBChB, FRANZCR, EBIR, ONZM, Director of Interventional Radiology, Auckland City Hospital, Auckland, New Zealand. "We have seen excellent distal penetration and backfilling of larger vessels in our tumor cases. In these cases, GPX provided effective, durable occlusions as confirmed using angiography several weeks post-GPX delivery."

The GPX Embolic Device is an innovative embolic designed for simple preparation and quick material delivery, as highlighted in case videos at the BEST of GEST event. GPX technology is a low viscosity, aqueous-based solution in a syringe that solidifies into a durable embolus upon delivery without polymerization or dimethyl-sulfoxide (DMSO) precipitation. GPX is designed to occlude blood vessels independent of a patient's coagulation situation.

GPX is packaged ready-to-use in a syringe, requires less than 1 minute of tableside preparation by the clinician, and may be delivered through standard catheters or small microcatheters (no complex mixing systems or special delivery catheters are necessary).*

Fluidx Medical Technology is a Salt Lake City, Utah based company focused on developing the GPX Embolic Device and other innovative medical technologies. The GPX Embolic Device is under development and does not have marketing clearance or approval in any market at this time. For investigational use (in New Zealand) only.

www.FluidxMedical.com

*Fluidx Medical Technology data on file.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-embolic-device-for-treating-tumors-highlighted-in-best-of-gest-session-at-the-global-embolization-oncology-symposium-technologies-gest-conference-301360729.html

SOURCE Fluidx Medical Technology

Recommended Stories

  • Walnuts Could Be the Secret to Living a Longer Life, According to a New Study

    Eating five servings of this snack each week can also decrease chances of death from cardiovascular disease by 25 percent.

  • A Guide to Healthy Fats vs. Unhealthy Fats

    Eating fats is key to health and longevity—as long as you eat the healthy kind of fats.

  • NeuroSphere Virtual Clinic Brings Relief to Rural Town

    Overwhelming hospital hallways and daunting distances fall before DBS and remote technology.

  • Digital Yuan Used in China’s Domestic Futures Market for First Time

    The interbank payment using the e-CNY afforded a zero cost, efficient, and convenient payment option in real time, according to the report.

  • USDC to Be Backed 100% by Cash, US Treasurys

    The USDC developer revealed last month that only 61% of tokens were backed by "cash and cash equivalents."

  • Branson’s Virgin Orbit to List in SPAC Deal Backed by Boeing

    (Bloomberg) -- Richard Branson’s Virgin Orbit agreed to go public through a reverse merger with NextGen Acquisition Corp. II that will value the satellite-launch company at $3.2 billion.Investors including Boeing Co. and AE Industrial Partners committed $100 million to Virgin Orbit through a private investment in public equity, according to a statement Monday. The merger is expected to provide the new company with $483 million in cash proceeds, bolstering its capital until regular launch operati

  • MSCI CEO Dismisses Concern Chinese Stocks Are ‘Uninvestable’

    (Bloomberg) -- MSCI Inc., the world’s biggest index provider, shook off concerns about the “investability” of Chinese stocks following recent Beijing’s regulatory crackdown, citing previous instances where markets rebounded in the aftermath. Regulatory compliance has weighed on China “every three, four, five years and obviously the markets have sold off at the time. But very quickly afterwards, the markets have recovered and gone through to new heights,” MSCI Inc. Chairman and Chief Executive Of

  • JPMorgan Private Bank Anne Zhang on Asia Corporate Credit

    Aug.23 -- Anne Zhang, Asia Head of Fixed Income, Currencies and Commodities (FICC) at J.P. Morgan Private Bank discusses opportunities and risks in Asia and China corporate credit. She speaks to David Ingles, Rishaad Salamat and Yvonne Man on 'Bloomberg Markets Asia'.

  • Billionaire Dan Loeb Snaps Up These 2 “Strong Buy” Stocks

    Daniel Loeb, CEO of Third Point, has a reputation for turning risk into success. His preferred strategy – of going in and cleaning up the mess – has built his firm into a $17 billion-plus asset management behemoth, with both hands in the US and international equity and credit securities markets. In the current environment, as we’re getting buffeted about by epoch-making public health crises, economic disruptions, and now foreign policy political disasters, Loeb sees a combination of risk and vol

  • Allstate Among Insurance Stocks Catching Index Attention

    Allstate announced an accelerated $750 million stock repurchase program, but it was already hitting our screens earlier.

  • Dow Futures Rise 145 Pts; Jackson Hole Symposium in Focus

    By Peter Nurse

  • GEODIS Opening E-Commerce Facilities

    Small e-commerce sellers are continually on the hunt for the right partner for their warehousing and logistics needs. 3PL GEODIS is expanding its eLogistics service to include four total facilities designed to accommodate e-commerce inventory stocking and shipping requirements for smaller brands. When all four locations are operational, GEODIS will be able to offer two-day shipping to 91% of the continental U.S. with standard shipping services. The eLogistics locations, including a currently ope

  • Equities gain, U.S. dollar falls; Fed seen less eager to taper

    NEW YORK (Reuters) – Global equity markets rose while the U.S. dollar dipped on Monday as investor concerns that the Federal Reserve would soon begin changing its accommodative monetary stance faded.

  • Is Coinbase Stock A Buy Right Now As Bitcoin Tops $50,000?

    Cryptocurrency exchange Coinbase debuted on April 14, but is sharply off its post-IPO highs. Is Coinbase stock a buy or sell in the current stock market rally?

  • EUR/USD Price Forecast – Euro Bounces to Kickoff Week

    The Euro has rallied significantly during the trading session on Monday, to at least try to recover after the massive selloff as of late.

  • U.S. Attracts European IPOs at the Fastest Pace Since 2000

    (Bloomberg) -- European businesses are rushing to list in the U.S. at the fastest pace in two decades, lured by the promise of higher valuations even as continental exchanges step up efforts to keep companies at home.Swiss sneaker brand On Holding AG, backed by tennis star Roger Federer, said Monday it will list in New York, while cryptocurrency miner Argo Blockchain Plc filed for a U.S. IPO on Friday. U.K. fintech firm Wise Plc plans to sell American depositary receipts.They’ll add to the $9.5

  • Twitter Stock Fluttering Between Bulls and Bears

    It’s understandable why some believe the recent Twitter (TWTR) stock makes no sense. After all, the social media platform operator did post strong results for the preceding quarter. Not only that, it’s moving ahead with its non-advertising monetization plans. I am bearish on this stock. Twitter's monetization plans could pave the way for the company to deliver materially higher earnings in the coming years. In turn, this may help to sustain and grow its valuation. Yet investors, by-and-large, se

  • Bitcoin, Pfizer COVID-19 Vaccine, Dogecoin, NFT And Disney: 5 Headlines From Weekend You May Have Missed

    There has been some exciting news from the biotech, cryptocurrency and corporate sectors that investors may have missed over the weekend. Here is a quick look at the top five stories. Bitcoin Crosses $50,000 Mark: Bitcoin (CRYPTO: BTC) reclaimed the crucial ,000 level for the first time since May on Sunday night amid the ongoing recovery in the cryptocurrency markets. The apex cryptocurrency has been steadily rising since mid-July and its market capitalization reached $942.83 billion at press ti

  • Federer-backed shoemaker On reveals revenue surge in U.S. IPO filing

    Federer had invested in On in 2019, according to the filing https://www.sec.gov/Archives/edgar/data/1858985/000119312521253415/d175570df1.htm#rom175570_14. It was not immediately known how much the Swiss tennis star has invested in the shoe firm. The 20-times Grand Slam winner had also teamed up with the company earlier this year to develop the Roger Pro tennis shoe.

  • NZD/USD Forex Technical Analysis – Confirmation of Closing Price Reversal Bottom Shifts Momentum to Upside

    The direction of the NZD/USD on Monday is likely to be determined by trader reaction to .6845 and .6837.